ATE285177T1 - Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen - Google Patents

Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen

Info

Publication number
ATE285177T1
ATE285177T1 AT96906519T AT96906519T ATE285177T1 AT E285177 T1 ATE285177 T1 AT E285177T1 AT 96906519 T AT96906519 T AT 96906519T AT 96906519 T AT96906519 T AT 96906519T AT E285177 T1 ATE285177 T1 AT E285177T1
Authority
AT
Austria
Prior art keywords
growth
cells
progenicial
hometopoietic
thiole
Prior art date
Application number
AT96906519T
Other languages
English (en)
Inventor
Robert L Capizzi
Alan F List
Original Assignee
Medimmune Oncology Inc
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Oncology Inc, Univ Arizona filed Critical Medimmune Oncology Inc
Application granted granted Critical
Publication of ATE285177T1 publication Critical patent/ATE285177T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96906519T 1995-02-17 1996-02-16 Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen ATE285177T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/390,713 US5846958A (en) 1995-02-17 1995-02-17 Methods of using aminothiols to promote hematopoietic progenitor cell growth
PCT/US1996/002188 WO1996025045A1 (en) 1995-02-17 1996-02-16 Thiols to promote hematopoietic progenitor cell growth

Publications (1)

Publication Number Publication Date
ATE285177T1 true ATE285177T1 (de) 2005-01-15

Family

ID=23543611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96906519T ATE285177T1 (de) 1995-02-17 1996-02-16 Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen

Country Status (10)

Country Link
US (2) US5846958A (de)
EP (1) EP0809437B1 (de)
JP (1) JP4057648B2 (de)
AT (1) ATE285177T1 (de)
AU (1) AU694847B2 (de)
CA (1) CA2213322C (de)
DE (1) DE69634074T2 (de)
ES (1) ES2235183T3 (de)
PT (1) PT809437E (de)
WO (1) WO1996025045A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US5994409A (en) * 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6953777B2 (en) * 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6489312B1 (en) * 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
IL152433A0 (en) 2000-04-26 2003-05-29 Univ Oregon Health Sciences Administration of a thiol-based chemoprotectant compound
US7053072B2 (en) * 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
CN1688293A (zh) * 2002-09-16 2005-10-26 韦思公司 多肽治疗剂口服给药的缓释配方及其使用方法
US20040146585A1 (en) * 2002-10-31 2004-07-29 Oregon Health & Science University Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia
US20070148154A1 (en) * 2004-12-17 2007-06-28 Universite Rene Descartes (Paris V) Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
WO2007096901A1 (en) * 2006-02-24 2007-08-30 Natco Pharma Limited Novel dihydrate form of amifostine and process for its preparation
US20130230580A1 (en) * 2010-09-14 2013-09-05 Paul S. Frenette Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration
CA3042858A1 (en) 2015-11-17 2017-05-26 The Burlington Hc Research Group, Inc. Methods for improved protection and delivery of aminothiols and analogs thereof
GB201706544D0 (en) * 2017-04-25 2017-06-07 Plasticell Ltd Method
CN110945118A (zh) 2017-07-28 2020-03-31 日产化学株式会社 培养基添加用组合物及培养基添加用化合物以及使用了它们的细胞或组织的培养方法
GB201817385D0 (en) * 2018-10-25 2018-12-12 Plasticell Ltd Therapy
TW202043199A (zh) 2019-01-30 2020-12-01 日商日產化學股份有限公司 醯肼化合物及激酶抑制劑
GB202303026D0 (en) 2023-03-01 2023-04-12 Plasticell Ltd Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892824A (en) * 1968-12-16 1975-07-01 Southern Res Inst S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
EP0394542A1 (de) * 1989-04-25 1990-10-31 American Cyanamid Company Wiederherstellung der Knochenmarkszellen mit synthetischen CSF-Induktoren
AU6647190A (en) * 1989-10-10 1991-05-16 University Of Rochester Method for producing bone marrow growth cell factors
MX9205549A (es) * 1991-09-30 1993-05-01 Jess G Thoene Metodo para el tratamiento de vih.
US5824664A (en) * 1993-03-26 1998-10-20 U.S. Bioscience, Inc. Suppression of HIV expression by organic thiophosphate

Also Published As

Publication number Publication date
CA2213322A1 (en) 1996-08-22
MX9706255A (es) 1998-08-30
EP0809437B1 (de) 2004-12-22
WO1996025045A1 (en) 1996-08-22
US5906984A (en) 1999-05-25
PT809437E (pt) 2005-05-31
ES2235183T3 (es) 2005-07-01
AU694847B2 (en) 1998-07-30
US5846958A (en) 1998-12-08
CA2213322C (en) 2008-05-13
DE69634074T2 (de) 2006-01-19
AU4986996A (en) 1996-09-04
JPH11504000A (ja) 1999-04-06
EP0809437A1 (de) 1997-12-03
JP4057648B2 (ja) 2008-03-05
DE69634074D1 (de) 2005-01-27
EP0809437A4 (de) 2001-05-09

Similar Documents

Publication Publication Date Title
DE69634074D1 (de) Thiole zur förderung des wachstumsvon hömatopoietischen vorläuferzellen
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
HUT75776A (en) Pyrazolo and pyrrolopyridines, their using, pharmaceutical compositions containing them and intermediates
ES2114786A1 (es) Tromboyetina. trombopoyetina recombinante y procedimiento de obtencion.
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
DE69004081D1 (de) Verwendung der Stearidonsäure zur Behandlung von Entzündungserkrankungen.
IT8521645A0 (it) Procedimento perfezionato per il trattamento di espansione del tabacco.
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
DE3778089D1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
HU9902668D0 (en) Compounds with growth hormone releasing properties
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
DE68911132D1 (de) Hematopoietische kolonien stimulierende faktoren zur verbesserung des lipoprotein/cholesterin-profils.
DK0674714T3 (da) Rekombinant gastrisk lipase fra hunde og farmaceutiske sammensætninger
DE69531554D1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
IS1986B (is) Notkun CD137 til að stuðla að fjölgun jaðar-einkjörnunga
DE69409961D1 (de) Triarylethylenderivate zur therapeutischen verwendung
ATE200893T1 (de) Butyrat-medikamentvorstufen der milchsäure
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
ATE43595T1 (de) Derivate des 2-furylbutyrolactons, ihre herstellung, diese enthaltende zusammensetzungen und ihre verwendung zur veraenderung des immunsystems bei saeugetieren.
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0809437

Country of ref document: EP

REN Ceased due to non-payment of the annual fee